When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody ...

According to Towards Healthcare research, the global polyclonal antibodies market size is calculated at USD 1.76 billion in ...

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced data from preclinical studies of three exatecan-based antibody drug ...

Mosquito-borne diseases like Malaria, Dengue, and Chikungunya are common in warm areas. Though similar in symptoms, they ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to ...

Growing Pipeline of ADC Candidates for Various Cancer Indications is Driving the IndustryDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The An ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Home > Press release: Power vaccination against cancer boosts ... New hope: MHH researchers are mobilising the immune system's defence against tumour cells within just two weeks using a two-phase ...